Provided by Tiger Trade Technology Pte. Ltd.

Natera

332.03
+7.192.21%
Post-market: 333.301.27+0.38%19:59 EDT
Volume:1.22M
Turnover:399.64M
Market Cap:47.55B
PE:-241.85
High:332.98
Open:325.00
Low:320.41
Close:324.84
52wk High:333.56
52wk Low:157.43
Shares:143.22M
Float Shares:139.00M
Volume Ratio:0.84
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3729
EPS(LYR):-1.5269
ROE:-12.54%
ROA:-8.08%
PB:26.11
PE(LYR):-217.46

Loading ...

Natera is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 14

Natera price target raised to $330 from $285 at Canaccord

TIPRANKS
·
Jul 14

Krystal Biotech Stock And 2 Biotech Names With Pipeline Catalysts

Simply Wall St.
·
Jul 13

Is Natera (NTRA) Fully Valued As Signatera Wins EU IVDR Certification?

Simply Wall St.
·
Jul 11

July 2026's Top Stock Picks Estimated To Be Trading Below Fair Value

Simply Wall St.
·
Jul 11

U.S. Stocks on the Move-natera, Nlight, Micron

Reuters
·
Jul 10

Natera is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jul 10

Analysts Are Bullish on These Healthcare Stocks: Natera (NTRA), Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Jul 10

Natera Shares Gain 2.8% After EU Certification for Cancer Test

THOMSON REUTERS
·
Jul 09

How New Signatera Colorectal Data and Trial Deals Could Shape Natera’s (NTRA) Long-Term Narrative

Simply Wall St.
·
Jul 09

Natera price target raised to $310 from $250 at Morgan Stanley

TIPRANKS
·
Jul 09

Natera Announces Ivdr Certification for Signatera™ Across Multiple Cancers

THOMSON REUTERS
·
Jul 09

Natera’s Signatera MRD Test Wins EU IVDR Certification for Multiple Cancers

Reuters
·
Jul 09

Natera Executive Chairman Matthew Rabinowitz Reports Disposal of 1,000 Common Shares Worth $280,000

Reuters
·
Jul 09

Natera President, Clinical Diagnostics Solomon Moshkevich Disposes of USD 819,636 in Common Shares

Reuters
·
Jul 07

Natera Announces Board Resignation Amid Governance Transition

TIPRANKS
·
Jul 07

Natera Director Monica Bertagnolli Resigns to Take National Academy of Medicine Role

Reuters
·
Jul 07

Natera is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jul 07

Natera Says Colorectal Liver Metastasis Test Identifies Patients Who Benefit From Chemotherapy

MT Newswires Live
·
Jul 06

Natera Signatera MRD Test Data in JAMA Oncology Links Chemo to Overall Survival Gain in Resected Metastatic Colorectal Cancer

Reuters
·
Jul 06